Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial

Drug and Alcohol Dependence

Volumn 128, Issue 1-2, 2013, Pages 71-76

  Saxon, Andrew J ^a   Ling, Walter ^b   Hillhouse, Maureen ^b   Thomas, Christie ^b   Hasson, Albert ^b   Ang, Alfonso ^b   Doraimani, Geetha ^b   Tasissa, Gudaye ^c   Lokhnygina, Yuliya ^c   Leimberger, Jeff ^c   Bruce, R Douglas ^d   McCarthy, John ^e   Wiest, Katharina ^f   McLaughlin, Paul ^g   Bilangi, Richard ^h   Cohen, Allan ⁱ   Woody, George ^j   Jacobs, Petra ^k  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Bi Valley Medicine Clinic Inc   (United States)

^f CODA Inc ^*  (United States)

^g Hartford Dispensary   (United States)

^h Connecticut Counseling Center ^*  (United States)

ⁱ Bay Area Addiction Research and Treatment   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

more..

Author keywords

Buprenorphine; Liver function; Methadone; Treatment outcome

Indexed keywords

ALANINE AMINOTRANSFERASE; AMPHETAMINE; ASPARTATE AMINOTRANSFERASE; BENZODIAZEPINE; BUPRENORPHINE PLUS NALOXONE; CANNABIS; COCAINE; DIAMORPHINE; HEPATITIS A ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; METHADONE; MORPHINE; OXYCODONE;

ADULT; ARTICLE; BRADYCARDIA; CHOLECYSTITIS; CONTROLLED STUDY; DRUG FATALITY; DRUG SEEKING BEHAVIOR; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NEW DAILY PERSISTENT HEADACHE; OPIATE ADDICTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SPONTANEOUS ABORTION; STOMACH ULCER; SUICIDAL IDEATION; SUICIDE ATTEMPT; THORAX PAIN; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; BUPRENORPHINE; DRUG COMBINATIONS; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; LIVER; MALE; METHADONE; MIDDLE AGED; NALOXONE; OPIOID-RELATED DISORDERS; TRANSAMINASES; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 84872387728     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.08.002     Document Type: Article

References (19)

1. Berson A., Fau D., Fornacciari R., Degove-Goddard P., Sutton A., Descatoire V., Haouzi D., Lettéron P., Moreau A., Feldmann G., Pessayre D. Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation. J. Hepatol. 2001, 34:261-269.
2. Berson A., Gervais A., Cazals D., Boyer N., Durand F., Bernuau J., Marcellin P., Degott C., Valla D., Pessayre D. Hepatitis after intravenous buprenorphine misuse in heroin addicts. J. Hepatol. 2001, 34:346-350.
3. Bogenschutz M., Abbott P.J., Kushner R., Tonigan J.S., Woody G.E. Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults. J. Addict. Med. 2010, 4:211-216.
4. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Brit. J. Addict. 1991, 86:1119-1127.
5. Hervé S., Riachi G., Noblet C., Guillement N., Tanasescu S., Goria O., Thuillez C., Tranvouez J.L., Ducrotte P., Lerebours E. Acute hepatitis due to buprenorphine administration. Eur. J. Gastroenterol. Hepatol. 2004, 16:1033-1037.
6. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N. Engl. J. Med. 2000, 343:1290-1297.
7. Jones H.E., Kaltenbach K., Heil S.H., Stine S.M., Coyle M.G., Arria A.M., O'Grady K.E., Selby P., Martin P.R., Fischer G. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N. Engl. J. Med. 2010, 363:2320-2331.
8. Kakko J., Grönbladh L., Svanborg K.D., von Wachenfeldt J., Rück C., Rawlings B., Nilsson L.H., Heilig M. A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. Am. J. Psychiatry 2007, 164:797-803.
9. Ling W., Wesson D.R., Charuvastra C., Klett C.J. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch. Gen. Psychiatry 1996, 53:401-407.
10. Mattick R., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2008, 16:CD002207.
11. Needle R., Fisher D.G., Weatherby N., Chitwood D., Brown B., Cesari H., Booth R., Williams M.L., Watters J., Andersen M., Braunstein M. Reliability of self-reported HIV risk behaviors of drug users. Psych. Addict. Behav. 1995, 9:242-250.
12. Petry N.M., Bickel W.K., Piasecki D., Marsch L.A., Badger G.J. Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine. Am. J. Addict. 2000, 9:265-269.
13. Schottenfeld R.S., Pakes J.R., Oliveto A., Ziedonis D., Kosten T.R. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch. Gen. Psychiatry 1997, 54:713-720.
14. Substance Abuse and Mental Health Services Administration, Office of Applied Studies Treatment Episode Data Set (TEDS) 2009, National Admissions to Substance Abuse Treatment Services - Highlights 2007, Rockville, MD.
15. Volkow N.D., McLellan T.A. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA 2011, 305:1346-1347.
16. Walsh S.L., June H.L., Schuh K.J., Preston K.L., Bigelow G.E., Stitzer M.L. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacol. (Berl.) 1995, 119:268-276.
17. Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., Bigelow G.E. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin. Pharmacol. Ther. 1994, 55:569-580.
18. Wesson D.R., Ling W. The clinical opiate withdrawal scale (COWS). J. Psychoactive Drugs 2003, 35:53-59.
19. Zuin M., Giorgini A., Selmi C., Battezzati P.M., Cocchi C.A., Crosignani A., Benetti A., Invernizzi P., Podda M. Acute liver and renal failure during treatment with buprenorphine at therapeutic dose. Dig. Liver Dis. 2009, 41:e8-e10.